DK3261681T3 - Radiofarmaceutiske opløsninger med fordelagtige egenskaber - Google Patents
Radiofarmaceutiske opløsninger med fordelagtige egenskaber Download PDFInfo
- Publication number
- DK3261681T3 DK3261681T3 DK16707063.0T DK16707063T DK3261681T3 DK 3261681 T3 DK3261681 T3 DK 3261681T3 DK 16707063 T DK16707063 T DK 16707063T DK 3261681 T3 DK3261681 T3 DK 3261681T3
- Authority
- DK
- Denmark
- Prior art keywords
- advantageous properties
- radiopharmaceutical solutions
- radiopharmaceutical
- solutions
- advantageous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1051—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from breast, e.g. the antibody being herceptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15156714.6A EP3061464B1 (en) | 2015-02-26 | 2015-02-26 | Radiopharmaceutical solutions with advantageous properties |
| US14/632,849 US9433690B1 (en) | 2015-02-26 | 2015-02-26 | Radiopharmaceutical solutions with advantageous properties |
| PCT/EP2016/053874 WO2016135200A1 (en) | 2015-02-26 | 2016-02-24 | Radiopharmaceutical solutions with advantageous properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3261681T3 true DK3261681T3 (da) | 2020-04-27 |
Family
ID=55446768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16707063.0T DK3261681T3 (da) | 2015-02-26 | 2016-02-24 | Radiofarmaceutiske opløsninger med fordelagtige egenskaber |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP3261681B1 (da) |
| JP (2) | JP6442072B2 (da) |
| KR (1) | KR102630614B1 (da) |
| CN (1) | CN107530456B (da) |
| AU (1) | AU2016223475B2 (da) |
| CA (1) | CA2973644C (da) |
| DK (1) | DK3261681T3 (da) |
| ES (1) | ES2784684T3 (da) |
| IL (1) | IL253815B (da) |
| MX (1) | MX369632B (da) |
| PH (1) | PH12017501519B1 (da) |
| RU (1) | RU2741794C2 (da) |
| SG (1) | SG11201706849SA (da) |
| UA (1) | UA122405C2 (da) |
| WO (1) | WO2016135200A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9433690B1 (en) | 2015-02-26 | 2016-09-06 | Sciencons AS | Radiopharmaceutical solutions with advantageous properties |
| WO2017220767A1 (en) * | 2016-06-24 | 2017-12-28 | Sciencons AS | Preparation of 212pb labeled monoclonal antibodies |
| FI3865155T3 (fi) * | 2020-02-13 | 2023-01-13 | Menetelmä vasta-aineen kohdespesifiseksi modifioimiseksi | |
| US20230330280A1 (en) * | 2020-09-15 | 2023-10-19 | Oncoinvent As | Preparations of radium-224 and progenies for use in radionuclide therapy in combination with dna repair inhibitors |
| IL308731A (en) * | 2021-05-21 | 2024-01-01 | Northstar Medical Tech Llc | UROKINASE PLASMINOGEN RECEPTOR TARGETED RADIOPHARMACEUTICALS |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5958672A (ja) * | 1982-09-28 | 1984-04-04 | Fujitsu Ltd | 磁気ディスク装置 |
| WO1989011475A1 (en) * | 1988-05-25 | 1989-11-30 | The United States Of America, As Represented By Th | Macrocyclic chelates and methods of use thereof |
| NO312708B1 (no) * | 2000-02-21 | 2002-06-24 | Anticancer Therapeutic Inv Sa | Radioaktive liposomer til terapi |
| US20030228256A1 (en) * | 2002-06-11 | 2003-12-11 | Inverardi Luca A. | Methods of achieving transplantation tolerance through radioablation of hemolymphopoietic cell populations |
| EP1735013B1 (en) * | 2004-02-20 | 2012-02-08 | Algeta ASA | Alpha- and beta-emitting hydroxyapatite particles |
| GB0423565D0 (en) * | 2004-10-22 | 2004-11-24 | Algeta As | Formulation |
| WO2012032043A1 (en) * | 2010-09-07 | 2012-03-15 | Areva Med Llc | 212 pb imaging |
| GB201105298D0 (en) * | 2011-03-29 | 2011-05-11 | Algeta Asa | Pharmaceutical preparation |
| ES2741643T3 (es) * | 2013-06-07 | 2020-02-11 | Nordic Nanovector Asa | Terapia de combinación que comprende un anticuerpo anti-CD20 y el anticuerpo monoclonal HH1 radiomarcado |
-
2016
- 2016-02-24 SG SG11201706849SA patent/SG11201706849SA/en unknown
- 2016-02-24 CA CA2973644A patent/CA2973644C/en active Active
- 2016-02-24 DK DK16707063.0T patent/DK3261681T3/da active
- 2016-02-24 WO PCT/EP2016/053874 patent/WO2016135200A1/en active Application Filing
- 2016-02-24 JP JP2017545666A patent/JP6442072B2/ja active Active
- 2016-02-24 MX MX2017010053A patent/MX369632B/es active IP Right Grant
- 2016-02-24 EP EP16707063.0A patent/EP3261681B1/en active Active
- 2016-02-24 UA UAA201708071A patent/UA122405C2/uk unknown
- 2016-02-24 ES ES16707063T patent/ES2784684T3/es active Active
- 2016-02-24 RU RU2017127720A patent/RU2741794C2/ru active
- 2016-02-24 AU AU2016223475A patent/AU2016223475B2/en active Active
- 2016-02-24 KR KR1020177027202A patent/KR102630614B1/ko active IP Right Grant
- 2016-02-24 CN CN201680008508.3A patent/CN107530456B/zh active Active
-
2017
- 2017-08-03 IL IL253815A patent/IL253815B/en active IP Right Grant
- 2017-08-22 PH PH12017501519A patent/PH12017501519B1/en unknown
-
2018
- 2018-11-21 JP JP2018218152A patent/JP6734350B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6734350B2 (ja) | 2020-08-05 |
| BR112017018201A2 (pt) | 2018-04-10 |
| WO2016135200A1 (en) | 2016-09-01 |
| AU2016223475B2 (en) | 2021-04-08 |
| KR20170129788A (ko) | 2017-11-27 |
| PH12017501519A1 (en) | 2018-02-05 |
| JP2019059747A (ja) | 2019-04-18 |
| AU2016223475A1 (en) | 2017-08-03 |
| EP3261681B1 (en) | 2020-01-15 |
| CN107530456A (zh) | 2018-01-02 |
| PH12017501519B1 (en) | 2018-02-05 |
| JP2018506574A (ja) | 2018-03-08 |
| MX2017010053A (es) | 2018-05-04 |
| JP6442072B2 (ja) | 2018-12-19 |
| CA2973644A1 (en) | 2016-09-01 |
| RU2741794C2 (ru) | 2021-01-28 |
| CA2973644C (en) | 2023-09-19 |
| UA122405C2 (uk) | 2020-11-10 |
| SG11201706849SA (en) | 2017-09-28 |
| EP3261681A1 (en) | 2018-01-03 |
| MX369632B (es) | 2019-11-14 |
| ES2784684T3 (es) | 2020-09-29 |
| RU2017127720A (ru) | 2019-03-26 |
| KR102630614B1 (ko) | 2024-01-26 |
| IL253815A0 (en) | 2017-09-28 |
| CN107530456B (zh) | 2021-02-26 |
| RU2017127720A3 (da) | 2019-09-05 |
| IL253815B (en) | 2019-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3283625T3 (da) | Nukleasemedieret genomeditering | |
| DK3331869T3 (da) | Muscarinagonister | |
| DK3305788T3 (da) | Janus-kinase-hæmmer | |
| DK3277719T3 (da) | Polypeptider | |
| DK3331528T3 (da) | Muskarinagonister | |
| DK3360890T3 (da) | Genterapi | |
| DK3386954T3 (da) | Dimere kontrastmidler | |
| DK3331529T3 (da) | Muskarinagonister | |
| DK3310450T3 (da) | Olie-vand-separator | |
| DK3270930T3 (da) | Præeklampsi | |
| DK3394281T3 (da) | Gærcelle | |
| DK3292136T3 (da) | Penicillin-g-acylaser | |
| IL253815B (en) | Radiopharmaceutical solutions with preferred properties | |
| DK3370794T3 (da) | Antimikrobielle opløsninger med forbedret stabilitet | |
| DK3274482T3 (da) | Stenborsknop | |
| DE112015006486A5 (de) | Inkubationsrinne | |
| DK3318308T3 (da) | Badmintonketsjer | |
| DE112016005599A5 (de) | Strahlungsgrill | |
| DE112015005906A5 (de) | Gurtschlossbringer | |
| ES1140083Y (es) | Descompatactador tetrafunción | |
| DE102015206660A8 (de) | Plattenaufteilanlage | |
| DK3096613T3 (da) | Forbedret måttestruktur med insekticid | |
| DE112016001124A5 (de) | Spannschutz | |
| DK3067295T3 (da) | Tank med låg | |
| DE102015000551A8 (de) | Rotationszerstäuberturbine |